Supplemental material
Hematology
Volume 27, 2022 - Issue 1
Open access
3,694
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial
Hiroyuki Muranushia Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
, Junya Kandaa Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, JapanCorrespondence[email protected]
, Masayuki Kobayashia Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;b Department of Hematology, Japan Baptist Hospital, Kyoto, Japan
, Takeshi Maedac Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan
, Toshiyuki Kitanod Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan
, Masaaki Tsujie Department of Hematology and Immunology, Otsu Red Cross Hospital, Otsu, Japan
, Yasunori Uedac Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan
, Takayuki Ishikawaf Department of Hematology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan
, Masaharu Nohgawag Department of Hematology, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan
, Mitsumasa Watanabeh Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan
, Kazunori Imadai Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan
, Toshinori Moriguchij Department of Internal Medicine, Kyoto-Katsura Hospital, Kyoto, Japan
, Mitsuru Itohk Department of Hematology, Kyoto City Hospital, Kyoto, Japan
, Hitoshi Ohnol Department of Hematology, Tenri Hospital, Tenri, Japanhttps://orcid.org/0000-0002-4348-4450
, Akihito Yonezawam Department of Hematology, Kokura Memorial Hospital, Kitakyushu, Japan
, Hirokazu Hiratan Department of Hematology, Kansai Electric Power Hospital, Osaka, Japan
, Nobuyoshi Arimad Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan
, Kohsuke Asagoeo Department of Hematology and Oncology, Shiga General Hospital, Moriyama, Japan
, Naoyuki Anzaip Department of Hematology and Oncology, Takatsuki Red Cross Hospital, Takatsuki, Japan
, Kayoko Nagataa Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
, Shinji Yasunoq Clinical Research Support Center, The Jikei University School of Medicine, Tokyo, Japan
, Yoshihiro Kuwabarar Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan
, Hiromi Kitaos Department of Data Science, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
, Ihhwa Kims Department of Data Science, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
, Kiyomi Kawagishis Department of Data Science, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan
, Kenji Ueshimat Center for Accessing Early Promising Treatment, Kyoto University Hospital, Kyoto, Japan
, Shinjiro Tominariu Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan
, Takeo Nakayamau Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japanhttps://orcid.org/0000-0002-7918-6252
, Kouhei Yamashitaa Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
& Akifumi Takaori-Kondoa Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
show all
Pages 239-248
|
Published online: 13 Feb 2022
Related Research Data
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.